HCA Healthcare
- Market cap
- 95.08B
- P/E (TTM)i
- 14.73
- P/Bi
- -14.32
- EPSi
- 28.33
- Div yieldi
- 0.68%
- 52W posi
- 43%
Anonymous reader poll. Unscientific, not investment advice.
HCA Healthcare shares were changing hands at 439.17, up 1.61% on the day. At current prices, the business is worth about 95.08B, the #238 most valuable US-listed company we track. Valuation-wise, the P/E sits at 14.58, broadly in line with the five-year average of 14.44. It pays a dividend yielding 0.68% on a trailing basis. The 22 analysts covering the stock are, on balance, at Buy, targeting an average of 456.50 (+4%). Against a 52-week band of 353.34-553.56, the shares are currently 43% of the way up.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 6 months.
- Its last 4 Sell calls were followed by roughly flat moves (-2%) three months out.
- Recent price momentum is +2.3% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has risen to 3.0% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 977 U.S. stocks StockVane covers.
Valuation B+
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 14.6x | Better than 66% |
| Forward P/E | 14.1x | Better than 63% |
| Price / Sales | 1.2x | Better than 79% |
| P/E vs own 5-yr range | 52nd pctl | Better than 57% |
Growth B
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 7.9% | Better than 56% |
| Net income CAGR (3Y) | 6.3% | Better than 52% |
| Free cash flow CAGR (3Y) | 23.1% | Better than 67% |
Profitability C+
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 41.5% | Better than 48% |
| Operating margin | 15.8% | Better than 52% |
| Net margin | 9.0% | Better than 42% |
Momentum C
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 2.8% | Better than 62% |
| 6-month return | -11.0% | Better than 21% |
| 12-month return (ex latest month) | -6.3% | Better than 24% |
| Distance below 52-week high | 21.4% | Better than 44% |
Financial Health D+
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 1.0x | Better than 23% |
| Debt to assets | 5,779.0% | Better than 0% |
| Interest coverage | 5.4x | Better than 44% |
| Free cash flow / net income | 113.4% | Better than 52% |
Analyst View D+
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 63.6% | Better than 39% |
| Upside to average target | 5.0% | Better than 9% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector, so capital-light software tends to grade lower there than utilities. Recomputed every 6 hours from our market data. Not investment advice, and not tailored to your financial situation, goals, or risk tolerance.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 432.20
- Open
- 431.76
- Day range
- 427.59 - 442.59
- Avg price
- 439.16
- Volume
- 999.02K
- Turnover
- 438.72M
- Turnover ratei
- 0.69%
- Volume ratioi
- 0.92
- Amplitudei
- 3.47%
- 52-week rangei
- 353.34 - 553.56
Valuation
- P/Ei
- 15.50
- P/E (TTM)i
- 14.73
- P/Bi
- -14.32
- EPSi
- 28.33
- Book value / shi
- -30.68
- Net profit
- 6.13B
- Net assets
- -6.64B
Share structure
- Market cap
- 95.08B
- Float capi
- 63.38B
- Shares out
- 216.50M
- Float sharesi
- 144.31M
Dividend & listing
- Div yield (TTM)i
- 0.68%
- Dividend (TTM)
- 3.00
- Listing date
- 1970-01-01
20.7% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+25.15M net over the window
Short interest
- Shares short
- 6.48M
- % of floati
- 2.99%
- Days to coveri
- 4.52
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of HCA Healthcare (HCA)?
HCA Healthcare last traded at 439.17. The quote on this page refreshes every few seconds while US markets are open.
What is HCA Healthcare's market cap?
About 95.08B.
What is the P/E ratio of HCA Healthcare?
The trailing twelve-month P/E is 14.73, above its own 5-year average of 14.44 — in the middle of its historical range (55.39% percentile). See the Valuation tab for the full history.
Does HCA Healthcare pay a dividend?
Yes. The trailing dividend yield is 0.68%. The 2025 payout was up 9.1% from 2024. See the Dividends tab for the full payment history.
Is HCA Healthcare a buy according to analysts?
The consensus of 22 analysts is a Buy rating, with an average 12-month price target of 456.50, which implies 3.9% upside from the current price. This is not investment advice.
What is HCA Healthcare's StockVane Quant Rating?
The StockVane Momentum strategy currently rates HCA Healthcare a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-10-08 06:24:33 · For reference only, not investment advice and not tailored to your situation.